TCRX - Tscan Therapeutics Inc
IEX Last Trade
5.69
0.050 0.879%
Share volume: 218,879
Last Updated: Fri 30 Aug 2024 09:59:55 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.64
0.05
0.89%
Fundamental analysis
10%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
3%
Performance
5 Days
-0.71%
1 Month
-19.80%
3 Months
-32.09%
6 Months
-16.10%
1 Year
149.12%
2 Year
101.07%
Key data
Stock price
$5.69
DAY RANGE
N/A - N/A
52 WEEK RANGE
$2.35 - $9.69
52 WEEK CHANGE
$1.29
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/07/2024
Company detail
CEO:
Region: US
Website: tscan.com
Employees: 127
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: tscan.com
Employees: 127
IPO year: -
Issue type: Common Stock
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
harnessing novel t cell systems to extend the promise of immunotherapy
Recent news